Abnormal KCNQ1 trafficking influences disease pathogenesis in hereditary long QT syndromes (LQT1)

被引:61
作者
Wilson, AJ
Quinn, KV
Graves, FM
Bitner-Glindzicz, M
Tinker, A
机构
[1] UCL, BHF Labs, London WC1E 6JJ, England
[2] UCL, Dept Med, London WC1E 6JJ, England
[3] Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 1EH, England
关键词
K plus channels; long QT syndrome; KCNQ1;
D O I
10.1016/j.cardiores.2005.04.036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: In the hereditary long QT syndromes the commonest defect is in the K+ channel pore forming subunit, KCNQ1. In this study we investigated the role that abnormal KCNQ1 trafficking has in the pathogenesis of the hereditary long QT syndrome (LQT1). Methods: We introduced nine missense and nonsense mutations occurring in LQT1 into the cDNA encoding KCNQ1 fused in frame to the green fluorescent protein. These mutations occur in syndromes that are inherited in both autosomal dominant and recessive fashions. We used biochemistry, electrophysiology and cell imaging to examine the behaviour of wildtype and mutant channel subunits expressed together with the auxiliary subunit KCNE1 expressed in CHO-K1 and C2C12 cells. Results: We found that a number of mutations in KCNQ1 are retained in the endoplasmic reticulum and unable to translocate to the plasma membrane. Furthermore, some mutations act in a dominant negative fashion and have the ability to suppress the trafficking of wildtype channel. We use fluorescence resonance energy transfer microscopy to show that this occurs because of direct interaction between the mutant subunit and wildtype channel in the endoplasmic reticulum. Finally, a number of specific and nonspecific pharmacological tools are unable to promote the delivery of these mutants to the plasma membrane. Conclusions: Our data revealed that channel trafficking may contribute to the pathogenesis of LQT1. (C) 2005 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:476 / 486
页数:11
相关论文
共 52 条
[1]   MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia [J].
Abbott, GW ;
Sesti, F ;
Splawski, I ;
Buck, ME ;
Lehmann, WH ;
Timothy, KW ;
Keating, MT ;
Goldstein, SAN .
CELL, 1999, 97 (02) :175-187
[2]   Stilbenes and fenamates rescue the loss of IKS channel function induced by an LQT5 mutation and other IsK mutants [J].
Abitbol, I ;
Peretz, A ;
Lerche, C ;
Busch, AE ;
Attali, B .
EMBO JOURNAL, 1999, 18 (15) :4137-4148
[3]   Truncated KCNQ1 mutant, A178fs/105, forms hetero-multimer channel with wild-type causing a dominant-negative suppression due to trafficking defect [J].
Aizawa, Y ;
Ueda, K ;
Wu, LM ;
Inagaki, N ;
Hayashi, T ;
Takahashi, M ;
Ohta, M ;
Kawano, S ;
Hirano, Y ;
Yasunami, M ;
Aizawa, Y ;
Kimura, A ;
Hiraoka, M .
FEBS LETTERS, 2004, 574 (1-3) :145-150
[4]   Dimerization: An emerging concept for G protein-coupled receptor ontogeny and function [J].
Angers, S ;
Salahpour, A ;
Bouvier, M .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2002, 42 :409-435
[5]   K(v)LQT1 and IsK (minK) proteins associate to form the I-Ks cardiac potassium current [J].
Barhanin, J ;
Lesage, F ;
Guillemare, E ;
Fink, M ;
Lazdunski, M ;
Romey, G .
NATURE, 1996, 384 (6604) :78-80
[6]   Regulators of G-protein signaling form a quaternary complex with the agonist, receptor, and G-protein - A novel explanation for the acceleration of signaling activation kinetics [J].
Benians, A ;
Nobles, M ;
Hosny, S ;
Tinker, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (14) :13383-13394
[7]   MOLECULAR MECHANISM FOR AN INHERITED CARDIAC-ARRHYTHMIA [J].
BENNETT, PB ;
YAZAWA, K ;
MAKITA, N ;
GEORGE, AL .
NATURE, 1995, 376 (6542) :683-685
[8]   Mechanisms of IKs suppression in LQT1 mutants [J].
Bianchi, L ;
Priori, SG ;
Napolitano, C ;
Surewicz, KA ;
Dennis, AT ;
Memmi, M ;
Schwartz, PJ ;
Brown, AM .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (06) :H3003-H3011
[9]   ER protein quality control and proteasome-mediated protein degradation [J].
Brodsky, JL ;
McCracken, AA .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 1999, 10 (05) :507-513
[10]   The role of the I-sK protein in the specific pharmacological properties of the I-Ks channel complex [J].
Busch, AE ;
Busch, GL ;
Ford, E ;
Suessbrich, H ;
Lang, HJ ;
Greger, R ;
Kunzelmann, K ;
Attali, B ;
Stuhmer, W .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (02) :187-189